Sign inJoin waitlistJoin the waitlist

David Liss

Program Director, Medical Toxicology Fellowship · Washington University/B-JH/SLCH Consortium

Credentials: · · · · · ·

History

Medical Toxicology Fellowship · Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present

Washington University in St Louis
2017–2018
Medical Toxicology
Washington University School of Medicine
2015–2017
Emergency Medicine
Washington University/B-JH/SLCH Consortium
2011–2015
University of Illinois College of Medicine
2007–2011
Northwestern University, Evanston, Illinois, 2003
2003–2007

Research

Do heroin overdose patients require observation after receiving naloxone?
Systematic review or meta-analysis · Clinical Toxicology · 2017 · 62 citations
Evaluation of Partial Oral Antibiotic Treatment for Persons Who Inject Drugs and Are Hospitalized With Invasive Infections
Clinical Infectious Diseases · 2020 · 57 citations
What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?
Review · Clinical Toxicology · 2013 · First of 4 authors · 56 citations

Michael Mullins
25 papers
Evan Schwarz
23 papers · 1 as a fellow
Kevin Baumgartner
14 papers · 14 as a resident
Laura Marks
5 papers · 5 as a fellow
Michael Durkin
5 papers
Stephen Liang
5 papers
Jason Devgun
4 papers
Ari Filip
3 papers · 3 as a fellow
Jon Cole
3 papers
Sarah Berg
3 papers · 3 as a fellow
David Warren
2 papers
Ellen Salmo
2 papers